A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

NCT06200207 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

680

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Systemic Inflammation

Interventions

DRUG: Ziltivekimab
DRUG: Placebo

Sponsor

Novo Nordisk A/S